Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Microplate Reader

By Drug Discovery Trends Editor | July 5, 2012

Berthold Technologies, specializing in bioanalytical instruments for the research and the diagnostics markets, presents the second generation of its multi-label TriStar² microplate reader.

TriStar² employs the new patent pending optical concept ALL-4-ONE, for the first time enabling luminescence, fluorescence and absorbance measurements with highest respective sensitivity as known from dedicated instruments. TriStar² is also capable of reading FRET, BRET and BRET².

In comparison to its predecessor the optics has been further improved and an improvement in detection limits in fluorescence has been achieved

• Less than 6 amol ATP per well
• Less than 0.3 fmol fluorescein per well

The instrument is characterized by an universal detector with extremely low noise for fluorescence and luminescence measurements and it is equipped with a photo diode for absorbance readings in addition. Furthermore optical filters can be used for luminescence measurements enabling BRET (e.g. functional assays for GPCR research) and multi-coloured luciferase reporter gene applications.

TriStar² can be fitted with up to 3 reagent injector – based on the proven and most accurate JET technology – and temperature control for the microplate compartment. Two of the injectors have their tips in reading position enabling the measurement of extremely fast reactions. New to the instrument is the reagent compartment placed at the front where the reagents are easily accessible and where they can be kept cooled by the addition of crushed ice when needed. For increased sample throughput TriStar² can integrated into lab automation systems. Special reagent mounts provide a safe fixation of small reagent vials und ensure complete consumption of the reagents through inclination of the vial.

Thus, TriStar² microplate reader offers a multitude of possibilities and a wide range of applications. Measurements of enzyme activities, phagocytosis, Calcium flux, cell viability, apoptosis, immuno assays, protein and DNA concentrations and protein-protein interactions are only a few of the many uses of TriStar².

The unit is operated via the proven and intuitive ICE software. Single and multiple endpoint readings are possible as well as kinetic and scanning measurements. The data are displayed in numerical and graphical formats and may be exported into Excel or printed.

Berthold Technologies


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE